The Effect of Linaclotide on Abdominal Girth in Participants With IBS-C

Discussion in 'Ironwood Pharmaceuticals' started by anonymous, Dec 28, 2017 at 9:48 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I understand this is another FDA mandated safety study due to the number of AE events with Linzess and abdominal pain and distention.
    I read it’s even worse with the controlled release version of Linzess which means longer the E. coli analog stays in your system the worse.
     

  2. anonymous

    anonymous Guest

    Nothing like adding inches to the gut to satisfy patients!...lol..
     
  3. anonymous

    anonymous Guest

  4. anonymous

    anonymous Guest

    It's not FDA mandated...